Macrophage colony-stimulating factor (M-C3F) is known to play an important role in osteoclast formation. However, its actions on mature cells have not been fully characterized. We now report that M-CSF dramatically stimulates osteoclastic motility and spreading; osteoclasts responded to a gradient of M-CSF with orientation, and random cell polarization occurred after isotropic exposure. M-CSF also supported the survival of osteoclasts by preventing apoptosis. Paradoxically, M-CSF inhibits bone resorption by isolated osteoclasts. We found that this was effected predominantly by reduction in the number of excavations. Thus, M-CSF showed a propensity to suppress resorption through a reduction in the proportion of cells that were resorbing bone. Our data suggest that apart from the established role of M-CSF in the provision of precursors for osteoclastic induction, a major role for M-CSF in bone resorption is to enhance osteoclastic survival, migration, and chemotaxis. It seems appropriate that during these processes resorptive functions should be suppressed. We suggest that M-CSF continues to modulate osteoclastic activity once osteoclasts are on resorptive sites, through regulation of the balance between resorption and migration, such that not only the quantity, but the spatial pattern of resorption can be controlled by adjacent M-CSF-secreting cells of osteoblastic lineage.
I
t has been established that the osteoclast is derived from hemopoietic precursors, from a lineage shared with mononuclear phagocytes, from which lineage it is induced to diverge by a contact-dependent interaction with bone marrow stromal cells (1) (2) (3) . This divergence is marked by the acquisition of characteristics not seen in other progeny of the monouudear phagocytic lineage, such as the ability to resorb bone, calcitonin receptors, and high levels of vitronectin receptor expression; and by the absence from osteoclasts of several enzymatic and antigenic characteristics of macrophages (4) (5) (6) (7) .
The deficiency of macrophages and ostcoclasts in osteopetrotic (op/op) mice has been shown to be due to the absence of macrophage colony-stimulating factor (M=CSF) x, caused by a mutation early in the coding region of the M=CSF gene (8, 9) . The ddideucy of both cell types can be made good, both in vivo and in hemopoietic cultures in vitro, by administration of M-CSF (10) (11) (12) (13) . For macrophages this de~Abbreviatlo~ used in ti~ pat~: CTR, calcitoffm receptor; M-CSF, macrophage colony-stimulating factor; TEM, transmission electron microscopy; TRAP, tartrate-resistant acid phosphatase_ Pendency on M-CSF is consistent with the well-described ability of M-CSF to promote the survival, proliferation, and functional capacity of macrophages (14) (15) (16) (17) (18) (19) . In contrast, the effects of M-CSF on mature osteoclasts, which are known to have M-CSF receptors (20) are less well characterized, and appeared, moreover, in the single reported study of M-CSF effects on mature osteoclasts, to show not enhanced function, as might be expected from the role of M-CSF in osteodast formation, but inhibition of bone resorption (21) . In view of these apparently paradoxical actions of M-CSF on osteoclast formation and function, we elected to more fully characterize the actions of M-CSF on mature osteoclasts.
Materlals and Methods
Recombinant human M-CSF was kindly provided by Dr. S. C. Clark, (Genetics Institute, Cambridge, MA). Mithramycin, cyclohexamide, and bovine serum albumin (BSA; used at I mg/ml) were purchased from Sigma Chemical Co. (Poole, UK). Medium 199 (Imperial Laboratories, Andover, UK) was used for osteoclast isolation and sedimentation, and Eagle's minimum essential medium (MEM; Imperial Laboratories) was used for subsequent incubations unless stated otherwise. Media were supplemented with 100 IU/ml benzylpenidllin and 100/~g/ml streptomycin (both from Imperial Laboratories). All incubations were performed at 37~ in 5% CO2 in humidified air.
Slices of devitalized bovine cortical bone, used as substrates for osteoclastic resorption, were prepared as previously described (22) . Bone slices (4 x 3 x 0.1 mm) were cut with a low-speed saw (Isomet Corp., Springfield, VA), cleaned by ultrasonication in sterile water, washed, immersed in alcohol, and stored dry at room temperature.
Isolation and Culture of Osteoclasts. Osteoclasts were disaggregated from neonatal rat or mouse long bones as previously described (23) . Wistar rats or MF-1 mice from the St. George's Hospital Medical School colony were killed by cervical dislocation within 3 d of birth. The femora, tibiae, and humeri were removed, freed of adherent soft tissues, and cut across their epiphyses. The bones were curetted with a scalpel bhde into 2 m1199 and the fragments were vigorously agitated using a plastic Pasteur pipette. Larger fragments were allowed to sediment for 30 s and the resulting suspensions were used in the experiments described in the next section. All experiments were designed in such a way that all variables received osteoclasts from the same suspension. All experiments were performed using rat osteoclasts unless otherwise specified.
Survival Studies. Bone cell suspensions were added either to three wells of a 100 x 18 mm multiwdl Petri dish (Sterilin, Teddington, UK) containing bone slices, or to wells of a 96-well plate (Sterilin) containing Thermanox (Gibco, Uxbridge, UK) coverslips and incubated for 15 rain. Bone slices and coverslips were then removed, washed in PBS, and placed into individual wells of a 96-well plate. Cells were incubated for 2 or 24 h in a total vol of 200 #1MEM/BSA in the presence of M-CSF or vehicle. Calcitonin receptor (CTR)-positive ceUs were identified using iodinated salmon CT (24) . For this, coverslips were washed in 199 and transferred to fresh wells containing 200 #1 199/BSA with labeled CT (0.2 nM). After 60 rain incubation at room temperature, coverslips were fixed in formalin, washed extensively, air dried, and then coated with K5 nuclear emulsion (Ilford Inc., Basildon, UK). They were developed after 7 d at 4~ and counterstained with Meyer's hematoxylin. Osteoclasts on bone slices were fixed for 2 rain in formalin and stained for tartrate-resistant acid phosphatase (TRAP) (25) . The substrate used was naphthol AS-B1 phosphate. Tartrate resistance was assessed in the presence of 0.05 M sodium tartrate. CTR-positive and TRAP-positive multinuclear cells were counted by light microscopy. In some experiments, osteoclastic survival was assessed by marking the position of a number of osteoclasts using a grid. Their video images were then recorded, and the survival of the same osteoclasts was assessed 1-24 h after the addition of M-CSF (5 ng/ml) or vehicle to the cultures.
Morphologic changes associated with apoptosis were assessed by acridine orange staining (Sigma Chemical Co.) (5 #g/m1) of coverslips fixed after incubation, and by transmission electron microscopy. Transmission electron microscopy (TEM) was performed on cells incubated for 6 or 24 h in the presence or absence of M-CSF (5 ng/ml). Cells adherent to 100-mm diameter petri dishes after incubation were washed with PBS and then fixed with 2 ml 5% glutaraldehyde in 0.2 M cacodylate buffer. They were then removed from the dish with a call scraper (Costar, High Wycombe, UK), pelleted by centrifugation, and processed for TEM.
Phenotypic Assessment. The potential of both rat and mouse osteoclasts to develop macrophagic markers normally not seen on osteoclasts was assessed after 2 or 24 h incubation on Thermanox coverslips in the presence of M-CSF (5 ng/ml). Immunocytochemistry was performed on these cultures with: CD45, a monoclonal antibody (mAb) to rat leukocyte common antigen; ED2, a mAb to rat macrophages; M1/70.15.1, a mAb to mouse macrophages; MoMa-2 (Serotec Ltd., Oxford, UK), a mAb to mouse monocytes and macrophages; and F4/80, a mAb to mouse macrophages (Dr. S. Gordon, Sir William Dunn School of Pathology, Oxford, UK) using standard immunoalkaline phosphatase staining techniques. All the above mAbs bind to monocytes and/or macrophages but not osteoclasts ([see reference 7; 26, 27] ; and unpublished observations). Nonspecific esterase activity was determined by the c~ naphthyl acetate method.
Assessment of Bone Resorption. The number of osteoclastic excavations and the plan area of bone resorbed were quantified by SEM after 6 and 24 h incubation as previously described (22) . Bone slices were removed from wells, immersed in 10% NaOCI for 10 min to remove cells, washed in distilled water, dried, and sputtercoated with gold. The entire surface of each bone slice was then examined in a scanning electron microscope ($90; Cambridge Instruments, Cambridge, UK). The depth of excavations was determined on the same specimens using a confocal microscope (I.asertec Corporation, London, UK).
Time-lapse Observations. The bone cell suspension, obtained as above, was added to 25 cm z tissue culture flasks (Sterilin) and incubated for 15 rain to allow osteoclast sedimentation and attachment. Nonadherent and loosely adherent cells were removed by washing with PBS. 10 ml of MEM/BSA were placed into the flasks and the cells were incubated for 30 man. Flasks were then sealed and placed in the incubation chamber of an Olympus 1MT-373 inverted microscope (Gallenkamp and Co., Ltd., London, UK). A suitable osteoclast-containing field was chosen and recorded for 30 rain on a time-lapse video recorder at 1/60 normal speed. Vehicle or M-CSF was then added in 0.5 ml prewarmed MEM/BSA and recording continued.
Measurement of Osteoclast Spread Area.
Osteoclasts were incubated on bone slices or Thermanox coverslips as above in the presence of M-CSF or vehicle for 2 h. They were then fixed and stained for TRAP activity. Osteodast spread area was determined with a light microscope linked to a computer-assisted image analyzer (Perceptive Instruments, Cambridge, UK).
Osteoclast Appearance in the Scanning Electron Microscope. Osteoclasts were sedimented onto bone slices as previously described and incubated for 30 min. They were then incubated in the presence of M-CSF (5 ng/ml) or vehicle for 5-60 min. Bone slices were fixed in 5% glutaraldehyde in 0.2 M cacodylate buffer for 30 min, dehydrated through graded alcohols, and critical-point dried from COz. Specimens were sputter-coated with gold and examined in a Zeiss DSM 940 scanning electron microscope (Zeiss, Oberkochen, Germany).
Assessment of Osteoclast Polarization. Orientation was evaluated
in a Zigmond orientation chamber as described by Zigmond (28) . Osteoclasts were sedimented onto the central area of a 22 x 40 mm glass coverslip for 15 rain. The coverslip was then washed and The cell-free area of the coverslip was wiped and the coverslip was inverted over the bridge. The chamber was placed into a 37~ incubator, and 100/zl 199/BSA was added to one well and 100/~1 199/BSA containing 0.1-10 ng/ml M-CSF was added to the other. After incubation for 30 min the osteoclasts present over the bridge were assessed for orientation with an inverted microscope using a x25 objective. Osteoclasts were adjudged to show orientation when pseudopodia were evident on one side of the cell and retraction filopodia and lobolxxtia were visible on the opposite side. When orientated, osteoclasts that showed pseudopodia in the 180 ~ sector towards the test well were scored positive, whereas the pseudopodia that were in the 180 ~ sector towards the control well were scored negative (28) . The same criteria were used for assessment of polarization of osteoclasts after incubation on coverslips in a uniform solution of M-CSF (0.05-50 ng/ml) for 30 min.
Statistical Methods. Differences between groups were analyzed with the Student's t test.
Results
In the absence of exogenous growth factor, isolated osteodasts showed morphological changes suggestive of apoptosis that were prevented by M-CSF (Figs. 1-3) . Within 24 h, most osteoclasts showed an abrupt change of behavior, in which previously well-spread cells became rounded, phasegranular, and formed blebs (Fig. 1) . Osteoclasts detached on gentle agitation of the culture vessel in this state, or if left undisturbed, showed nuclear and cytoplasmic disintegration after a period of hours. Cells stained with acridine orange after fixation showed that changes in nuclear texture, with chromatin dumping, preceded the terminal rounding and blebbing phase identified in phase contrast observations, with nuclear changes becoming visible within 2 h of isolation (Fig.  2) . Electron microscopical observations also revealed nuclear changes characteristic of apoptosis (Fig. 3) . Osteodastic apoptosis was neither prevented nor induced by cycloheximide (1 /~M) or mithramycin (100 riM), suggesting that in osteoclasts, activation of a latent enzyme (29) may be involved in the process (data not shown).
Osteodastic survival was considerably enhanced by addition of M-CSF to cultures, whether survival was measured as TRAP-or CTR-positive multinudear cells (Fig. 4) . Enhanced survival was also documented by observation of particular osteoclasts by time-lapse video microscopy for 24 h. We found that 2 out of 20 control cells, and 13 out of 20 osteoclasts incubated with M-CSF (5 ng/ml) survived. Apoptosis in serum-flee medium appeared to be initiated and become irreversible relatively soon after osteoclast isolation, since M-CSF addition 2 h after isolation did not significantly increase survival compared to M-CSF-ffee cultures (Fig. 4) . This action of M-CSF to sustain osteoclastic survival was reflected in suppression of apoptosis-associated changes in nuclear morphology (Figs. 2 and 3) .
Because we have previously found (21) that M-CSF inhibits bone resorption, the improved survival of osteoclasts in M-CSF was unexpected. We therefore tested, in view of the close lineage relationship between macrophages and osteoclasts, for evidence of a possible action for M-CSF in diverting osteodasts towards an alternative, macrophagic role. We found, however, that rat osteodasts incubated in M-CSF (5 ng/ml) for 24 h remained nonspecific esterase-negative, despite suppression of bone resorption by M-CSF during this time; and both rat and murine (which similarly were suppressed from apoptosis by M-CSF [data not shown]) osteoclasts remained negative for all the antigenic markers used, which are present on macrophages but not detected on osteodasts (7, 26, 27) . Moreover, osteoclasts incubated for 24 h with M-CSF (Fig.  4) remained strongly CTR-positive, not subjectively different in grain density from osteoclasts incubated for 2 h. Since macrophages are unable to excavate bone (30), a further clue to a possible action of M-CSF to induce osteoclasts to undertake macrophagic differentiation might be reflected in a progressive decline in the ability of the cells to resorb bone. Thus, the ability of M-CSF to inhibit resorption would become greater with increasing incubation time. We found that the reverse was the case. Resorption-suppression was two orders of magnitude greater for resorption measured after 6 h of incubation (Fig. 5 ), than after 18 h (21), and resorptionsuppression at 6 h showed a very similar sensitivity to M-CSF to the dose-responsiveness of osteoclasts for increased survival by M-CSF (Fig. 4) . Moreover, if resorption was compared after 6 and 24 h in the same experiment (Table 1 ), it appears that while the resorption rate falls in control cultures, perhaps attributable to the decrease in osteodast number during culture, the resorption rate was sustained in M-CSFincubated cultures at a relatively steady rate through the incubation period. Thus, we found no evidence of a progressive increase with time in resorption-suppression by M-CSF, which might have reflected differentiation of osteoclasts towards a nonresorptive cell type.
Similar to our results on plastic, osteoclast survival on bone was enhanced by the presence of M-CSF (Fig. 4 and Table  1 ). This is unlike our experience in similar experiments which were performed in the presence of serum (21), which improves the survival of osteoclasts in vitro (data not shown). The lack of significant inhibition of bone resorption measured after 24 h in the present experiment is attributable to the impaired survival of osteoclasts in the absence of M-CSF and serum (Table 1) . (27) Osteoclasts were incubated on bone slices for 6 or 24 h in M-CSF (50 ng/ml) or vehicle, before quantification of cell number and bone resorption. Numbers in parentheses represent the number of observations. Each group is derived from seven experiments, with six bone slices per variable per experiment. A random sample of excavations was assessed for excavation depth. S p <0.05 vs. control; "p <0.01 vs. 6 h; * p <0.01 vs. control.
The reduction in excavation depth by M-CSF (Table 1) excludes the possibility (which would resolve the discordant actions of M-CSF to stimulate survival and suppress resorption), that the previously identified decrease in plan area of resorption (21) might have been associated with an increase in resorption depth.
In control cultures most osteoclasts produced an excavation (see Table 1 ). Since the number of excavations did not increase between 6 and 24 h, there appeared to be little initiation of fresh excavations after 6 h of incubation in control cultures (Table 1) , consistent with the poor viability of these cells. However, osteoclasts incubated with M-CSF seemed to continue to initiate resorption after 6 h since the number of excavations was more than doubled at 24 h compared to 6 h. Excavation size (plan area and depth of each excavation) was only slightly reduced by M-CSF, while the proportion of osteoclasts resorbing bone appeared to have been reduced at 6 h from ~80% in control cultures to '~20% in M-CSF.
Thus, the predominant explanation for the suppression of bone resorption by M-CSF appeared to be through a reduction in the proportion of osteoclasts that were resorbing bone, rather than through an equal suppression of the activity of each osteoclast.
The dear suppression of bone resorption by M-CSF seemed perverse for a cytokine that supported osteoclastic survival, and raised the possibility that M-CSF might stimulate some function in osteoclasts other than bone resorption. We found that addition of M-CSF to osteoclasts in serum-free medium was consistently followed within 30 s by a dramatic change in behavior (Fig. 6) , consisting of a rapid increase in pseudopodial motility, with the formation of a peripheral phasedense band that soon encircled the cell, associated with waves of pseudopodial activity starting at the cell periphery and passing towards the centre of the cell. This was accompanied by cell spreading. Motility then returned towards control levels, and cytoplasmic spreading was maintained, for at least the duration of the experiments (24 h), at a higher level. The cell spreading phenomenon showed a dose-response relationship, and occurred on both plastic and bone substrates (Figs. 7 and 8). After incubation in M-CSF, osteodasts showed an appearance similar to that seen in serum, and the morphological change induced by M-CSF was not consistent in the presence of serum (data not shown). No change in behavior was observed after addition of vehicle. The rapid, dramatic, transient change in behavior resembled a response to chemotactic agents (31) . Such agents also characteristically induce orientation in gradients, and polarization in isotropic concentrations of the same agents (32, 33) . We found that osteodasts oriented towards an M-CSF source (Figs. 9 and 10) , and an increased proportion of osteoclasts became polarized after 30 rain of incubation in 0.05 and 0.5 ng/ml of M-CSF (percent _+ SEM:vehide 28 _+ 18; M-CSF 0.05 ng/ml:66 _+ 17 [P <0.01 vs. control]; 0.5 ng/ml:46 _+ 11 IF <0.05] [six cultures per variable]). At concentrations of 5 ng/ml and above osteoclasts regularly showed active pseudopods over at least most, and generally the whole of their circumference, a phenomenon also observed after incubation of other target cells in high uniform concentrations of chemotactic agents (32, 33) .
Discussion
The actions of M-CSF on cells of the mononuclear phagocyte system have been well characterized, and include promotion of survival, proliferation, differentiation, and several aspects of mature cell function (14) (15) (16) (17) (18) . Although it has recently been shown that M-CSF is also important in osteoclast formation (8, 9) , much less is known about the mechanisms by which M-CSF acts in osteoclast differentiation, or about its role, ff any, in the regulation of the function of mature cells.
We now report that M-CSF promotes the survival of mature osteoclasts through suppression of apoptosis. Survival was enhanced at very low concentrations of M-CSF, suggesting that the phenomenon might have physiological significance. However, although this is the first identification of an osteoclastic survival factor, others may exist. Kodama et al. (34) have shown prolonged survival of osteoclasts in op/op mice, which are deficient in M-CSF, after a single injection of M-CSF.
The ability of M-CSF to support osteoclast survival makes it even more surprising that it inhibits bone resorption in vitro. Nevertheless, we found that the responsiveness of os- teoclasts to resorption-inhibition was very similar to their sensitivity to M-CSF as a survival factor. It seems perverse that increased survival be associated with a reduction in the primary function of a cell. One possibility, in view of the shared origin of osteoclasts and macrophages, is that M-CSF might enhance macrophagic differentiation in osteoclasts.
Thus, it is known that in the presence of bone marrow stromal cells, hemopoietic precursors differentiate into osteodasts, but in the presence of M-CSF alone, the same precursors differentiate only into macrophages (1, 3) . Just as mononuclear phagocytes may dedifferentiate on removal of M-CSF (35) , and have been found by some (36) (but not all [27] ) workers to be capable of differentiation into osteoclasts in the presence of stromal osteoclast-forming activity (SOFA), it may be that, upon removal from SOFA, osteodasts become capable of macrophagic differentiation in the presence of M-CSF.
Our results do not support this possibility. We found no evidence for macrophagic differentiation of osteoclasts in the presence of M-CSF. Moreover, if resorption inhibition by M-CSF were explicable as differentiation towards macrophages, which cannot excavate bone (30), we would anticipate a progressive decline in the rate of resorption by osteoclasts incubated in M-CSF. We found that bone resorption was inhibited to a similar degree early and late in the incubation period.
A second possible explanation for the inverse actions of M-CSF on osteoclastic survival and resorptive function might be that the stimulation of osteodasts, implied by its potent action on survival, may be of some aspect of osteoclastic function that is not directly involved in the process of bone resorption itself.
Our results suggest that M-CSF plays a role in osteoclastic migration and chemotaxis. We found that M-CSF, within 30 s of application, caused a dramatic increase in pseudopodial motility in isolated osteoclasts, associated with increased cytoplasmic spreading. The dramatic and transient behavioral change is typical of the response of cells to a rapid change in the concentration of a chemotactic agent (31) (32) (33) 37) . Also typical of a chemotactic response, osteodasts showed positive orientation to M-CSF gradients, and an increase in the proportion of cells demonstrating random polarization in isotropic concentrations of M-CSF. Polarization of pseudopodial activity implies migration in the direction of the expanded, leading pseudopods in many cell types, including osteoclasts (38, 39; see Fig. 1, a-c) .
Bone resorption occurs throughout development and adult life in intricate and dynamic patterns. There is much evidence that this spatial organization of osteoclastic activity is under the control of cells of the osteoblastic lineage (4, 40, 41) , which have been shown to produce M-CSF (42) . Our data suggest that the function of this M-CSF production may be to attract osteoclasts to resorptive sites, and to maintain their survival during migration.
A role for M-CSF to induce osteodastic migration through tissues may be analogous to its role in the M-CSF-dependent migration through tissues of trophoblastic cells (43) , monocytes (44, 45) , and some c-f ms-expressing breast cancer cells (46) . There is evidence that suggests that osteoclasts might share other migratory mechanisms with mononuclear phagocytes: recently, osteoclasts have been shown to possess receptors for urokinase-type plasminogen activator (47) , and to produce messenger RNA for collagenase (48) . These neutralpH active proteinases appear not to play a direct role in the excavation of bone (49), but they are requ/red for bone resorption in intact bone tissue (50), perhaps to enable osteoclastic migration to resorptive sites.
Although M-CSF can stimulate some functions in macrophages as in osteoclasts, it is interesting that M-CSF suppresses activities that are directly related to the ultimate function of both cell types; bone resorption in osteoclasts, and superoxide generation in macrophages (51) . Both activities may be inappropriate during migration, and this suggests that a primary role of M-CSF might be to induce migration of target cells through tissues.
It is intriguing to note that the dominant action of M-CSF on bone resorption by osteoclasts was not to suppress the rate of resorption by all osteoclasts equally, but to reduce the proportion of osteodasts that were resorbing bone. This suggests that bone resorption and migration might represent alternative states of osteoclastic activity, that are to some extent mutually exclusive. Consistent with this, resorptive surfaces in vivo show a scalloped appearance, suggestive of episodic resorption and migration (52) (53) (54) . We have previously found that contact with bone mineral induces resorptive behavior in osteoclasts; and because the mineral phase of bone is resorbed more rapidly than the organic phase, resorption itself progressively reduces mineral contact (55) . Thus, on bone surfaces in vivo, as on our bone slices in vitro, mineral contact and M-CSF exposure might represent opposing stimuli that determine the behavioral state of osteodasts, such that as resorption proceeds, migration becomes increasingly likely. Consistent with this thesis is the relative shallowness of excavations in normal animals in vivo, compared with the more irregular resorptive surface in SEM photographs of bone surfaces from op/op animals lacking M-CSF (56) .
Our data thus suggest that the role of M-CSF in bone resorption is to enhance osteoclastic survival, migration, and chemotaxis. It seems appropriate that during these processes resorptive functions should be suppressed. We suggest that M-CSF continues to modulate osteoclastic activity once osteodasts are on resorptive sites through regulation of the balance between resorption and migration, such that not only the quantity but the spatial pattern of resorption can be controlled by adjacent M-CSF-secreting cells of osteoblastic lineage.
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